User profiles for Johanna A. Joyce
Johanna JoyceUniversity of Lausanne Verified email at unil.ch Cited by 36515 |
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
…, JC Sutton, EC Holland, D Daniel, JA Joyce - Nature medicine, 2013 - nature.com
Glioblastoma multiforme (GBM) comprises several molecular subtypes, including proneural
GBM. Most therapeutic approaches targeting glioma cells have failed. An alternative strategy …
GBM. Most therapeutic approaches targeting glioma cells have failed. An alternative strategy …
Microenvironmental regulation of tumor progression and metastasis
DF Quail, JA Joyce - Nature medicine, 2013 - nature.com
Cancers develop in complex tissue environments, which they depend on for sustained
growth, invasion and metastasis. Unlike tumor cells, stromal cell types within the tumor …
growth, invasion and metastasis. Unlike tumor cells, stromal cell types within the tumor …
Microenvironmental regulation of metastasis
JA Joyce, JW Pollard - Nature reviews cancer, 2009 - nature.com
Metastasis is a multistage process that requires cancer cells to escape from the primary
tumour, survive in the circulation, seed at distant sites and grow. Each of these processes …
tumour, survive in the circulation, seed at distant sites and grow. Each of these processes …
T cell exclusion, immune privilege, and the tumor microenvironment
Effective immunotherapy promotes the killing of cancer cells by cytotoxic T cells. This requires
not only that cancer-specific T cells be generated, but also that these T cells physically …
not only that cancer-specific T cells be generated, but also that these T cells physically …
Therapeutic targeting of the tumor microenvironment
L Bejarano, MJC Jordāo, JA Joyce - Cancer discovery, 2021 - AACR
This review provides a comprehensive analysis of the current therapies targeting the TME,
combining a discussion of the underlying basic biology with clinical evaluation of different …
combining a discussion of the underlying basic biology with clinical evaluation of different …
The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
…, JT Huse, EC Holland, JC Sutton, JA Joyce - Science, 2016 - science.org
INTRODUCTION Therapies targeted against the tumor microenvironment (TME) represent a
promising approach for treating cancer. This appeal arises in part from the decreased …
promising approach for treating cancer. This appeal arises in part from the decreased …
[PDF][PDF] The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
KE de Visser, JA Joyce - Cancer Cell, 2023 - cell.com
Cancers represent complex ecosystems comprising tumor cells and a multitude of non-cancerous
cells, embedded in an altered extracellular matrix. The tumor microenvironment (TME) …
cells, embedded in an altered extracellular matrix. The tumor microenvironment (TME) …
[PDF][PDF] The microenvironmental landscape of brain tumors
DF Quail, JA Joyce - Cancer cell, 2017 - cell.com
The brain tumor microenvironment (TME) is emerging as a critical regulator of cancer
progression in primary and metastatic brain malignancies. The unique properties of this organ …
progression in primary and metastatic brain malignancies. The unique properties of this organ …
[PDF][PDF] Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells
Brain malignancies encompass a range of primary and metastatic cancers, including low-grade
and high-grade gliomas and brain metastases (BrMs) originating from diverse …
and high-grade gliomas and brain metastases (BrMs) originating from diverse …
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
…, KE Hunter, AL Garfall, T Berman, JA Joyce - Genes & …, 2010 - genesdev.cshlp.org
Innate immune cells can constitute a substantial proportion of the cells within the tumor
microenvironment and have been associated with tumor malignancy in patients and animal …
microenvironment and have been associated with tumor malignancy in patients and animal …